Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (411-420 of 535) with videos related to

Pageof 54
Sort By:
Journal of Virology|October 16, 2015
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan VirusesFrederick W Holtsberg, Sergey Shulenin, Hong Vu, et al.
Blood Advances|January 4, 2018
Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPsJoseph R Francica, Daniel E Zak, Caitlyn Linde, et al.
Nature Communications|June 28, 2022
Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platformsCaroline G Atyeo, Lydia L Shook, Sara Brigida, et al.
Nature Communications|June 12, 2021
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lungNanda Kishore Routhu, Narayanaiah Cheedarla, Venkata Satish Bollimpelli, et al.
Med (New York, N.Y.)|November 23, 2021
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitorsRita E Chen, Matthew J Gorman, Daniel Y Zhu, et al.
Science Translational Medicine|February 22, 2022
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaquesXuan He, Malika Aid, Abishek Chandrashekar, et al.
Nature Communications|October 3, 2022
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concernMatthew R Chang, Luke Tomasovic, Natalia A Kuzmina, et al.
The Journal of Infectious Diseases|September 9, 2020
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, MassachusettsVivek Naranbhai, Christina C Chang, Wilfredo F Garcia Beltran, et al.
Science Immunology|July 22, 2022
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaquesAnusmita Sahoo, Andrew T Jones, Narayanaiah Cheedarla, et al.
Cell|September 27, 2016
A Functional Role for Antibodies in TuberculosisLenette L Lu, Amy W Chung, Tracy R Rosebrock, et al.
Pageof 54

Showing results (411-420 of 535) with videos related to

Sort By:
Pageof 54
Journal of Virology|October 16, 2015
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan VirusesFrederick W Holtsberg, Sergey Shulenin, Hong Vu, et al.
Blood Advances|January 4, 2018
Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPsJoseph R Francica, Daniel E Zak, Caitlyn Linde, et al.
Nature Communications|June 28, 2022
Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platformsCaroline G Atyeo, Lydia L Shook, Sara Brigida, et al.
Nature Communications|June 12, 2021
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lungNanda Kishore Routhu, Narayanaiah Cheedarla, Venkata Satish Bollimpelli, et al.
Med (New York, N.Y.)|November 23, 2021
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitorsRita E Chen, Matthew J Gorman, Daniel Y Zhu, et al.
Science Translational Medicine|February 22, 2022
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaquesXuan He, Malika Aid, Abishek Chandrashekar, et al.
Nature Communications|October 3, 2022
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concernMatthew R Chang, Luke Tomasovic, Natalia A Kuzmina, et al.
The Journal of Infectious Diseases|September 9, 2020
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, MassachusettsVivek Naranbhai, Christina C Chang, Wilfredo F Garcia Beltran, et al.
Science Immunology|July 22, 2022
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaquesAnusmita Sahoo, Andrew T Jones, Narayanaiah Cheedarla, et al.
Cell|September 27, 2016
A Functional Role for Antibodies in TuberculosisLenette L Lu, Amy W Chung, Tracy R Rosebrock, et al.
Pageof 54